Müllerian agenesis is a congenital condition in which the uterus and upper portion of the vagina fail to develop, despite the person having typical female chromosomes (46,XX), functioning ovaries, and normal external anatomy. It affects roughly 1 in 4,500 to 5,000 women and is medically known as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. The condition develops early in fetal life, when the Müllerian ducts that normally form the uterus, fallopian tubes, and upper vagina do not grow as expected, and most people learn of it only when a teenager does not begin menstruating.
What Happens During Fetal Development
The Müllerian ducts are a pair of embryonic structures that, in a typical female fetus, fuse and differentiate into the reproductive tract. In Müllerian agenesis, these ducts fail to develop properly between roughly the fifth and sixth weeks of pregnancy.1PubMed Central. Mayer-rokitansky-kuster-hauser syndrome: embryology, genetics and clinical and surgical treatment Because the ovaries develop from a completely separate embryonic tissue, they are unaffected. That means hormone production, puberty, and secondary sexual characteristics like breast development and body hair all proceed normally. The disconnect between a fully feminized appearance and the absence of menstruation is what makes the diagnosis so unexpected for both patients and families.
How the Diagnosis Usually Unfolds
The most common scenario is a teenager visiting a doctor because she has not gotten her period by age 15 or 16, even though other signs of puberty appeared on schedule. Because the ovaries function normally, blood hormone levels can look entirely unremarkable, which sometimes leads clinicians down the wrong diagnostic path. One case series highlighted how a midcycle surge in hormones can mimic patterns seen in ovarian failure, potentially delaying the correct diagnosis if the timing of blood draws is not carefully considered.2JCEM Case Reports. Diagnostic puzzles in primary amenorrhea: a report of 3 cases Since there is no menstrual cycle to track, clinicians cannot easily predict where in the ovarian cycle a patient’s bloodwork will fall.
A pelvic ultrasound typically reveals the absent or rudimentary uterus. MRI provides more detailed imaging and can identify the exact extent of the anomaly, including whether tiny uterine remnants exist and what the kidneys look like. The diagnosis can be emotionally devastating, arriving at an age when identity, body image, and social belonging are already in flux.
Why It Happens and What Genetics Has Uncovered So Far
Despite decades of research, the genetics of MRKH syndrome remain frustratingly incomplete. Most cases appear to arise sporadically, with no clear family history. Several candidate genes have been investigated, but only WNT4 has been firmly linked to a specific subtype that also involves excess male-pattern hormones.3PubMed. Genetics of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome More recently, researchers identified a gene called GREB1L as a promising lead. In one study comparing women with MRKH to thousands of controls, rare variants in GREB1L were about 13 times more common in the affected group, though the finding still accounted for only a small fraction of cases.4American Journal of Human Genetics. Rare variants in GREB1L are associated with Müllerian agenesis and implicated in broadening the mutational spectrum of Mayer-Rokitansky-Küster-Hauser syndrome
The emerging picture is that MRKH likely involves multiple genes and possibly environmental triggers acting together during a narrow window of fetal development. There is also evidence that epigenetic changes, specifically altered DNA methylation patterns around a gene called PAX2, may play a role. Researchers found unusual methylation at the PAX2 gene’s promoter region in individuals with Müllerian duct anomalies, suggesting that how genes are switched on and off during embryonic development matters as much as the genes themselves.5PubMed. Aberrant DNA methylation in the PAX2 promoter is associated with Müllerian duct anomalies This area of research is still young, but it helps explain why even identical twins can be discordant for the condition.
Type I Versus Type II and the MURCS Association
MRKH is typically classified into two forms. Type I is the isolated version, in which the uterus and upper vagina are absent but no other organs are significantly affected. Type II, which is actually more common, comes with additional anomalies affecting the kidneys, spine, and sometimes the heart or hearing.6PubMed Central. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome
Kidney malformations are the most frequently seen associated problem, reported in roughly a third of patients. A nationwide registry study found kidney issues in about 34% of those evaluated, though a similar proportion had never even had urinary tract imaging done, meaning the true prevalence could be higher.7Human Reproduction. Prevalence and patient characteristics of Mayer–Rokitansky–Küster–Hauser syndrome: a nationwide registry-based study Kidney anomalies range from a single kidney to an abnormally positioned one, and most do not cause symptoms, but they can matter for future health decisions and should be checked.
When Müllerian agenesis, kidney anomalies, and spinal malformations occur together, the pattern is called the MURCS association. Spinal findings typically involve fused vertebrae in the neck, a condition known as Klippel-Feil syndrome. One study of patients with the atypical form found that congenital spinal abnormalities appeared in about a quarter of them, and ten patients had the full MURCS triad.8PubMed. Spinal abnormalities and the atypical form of the Mayer-Rokitansky-Küster-Hauser syndrome A systematic review of MURCS cases found that cervical vertebral fusion, short neck, and short stature each appeared in over half the patients, while scoliosis showed up in about one in five.9PubMed. Spinal Anomalies in MURCS Association: A Rare Case Report and Systematic Review of the Literature The takeaway for anyone newly diagnosed is that thorough imaging of the kidneys and spine should be part of the initial workup, even if there are no symptoms.
Creating a Functional Vagina Without Surgery
Because the upper vagina is absent or extremely short, treatment is needed for penetrative sexual activity. The first-line approach recommended by most specialty groups is vaginal dilation therapy, a non-surgical method in which progressively larger dilators are used to gradually stretch and create a vaginal canal. It sounds simple, and in a way it is, but it requires patience and consistent effort over weeks to months.
A large study following 245 consecutive patients managed with dilation therapy concluded that surgery was rarely, if ever, necessary.10Fertility and Sterility. Mayer-Rokitansky-Küster-Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators Other research has confirmed that dilation creates a vaginal environment that is more physiologically natural than surgical alternatives, with lower complication rates and no scarring.11PubMed Central. Non-surgical treatment of vaginal agenesis using a simplified version of Ingram’s method A prospective study with one-year follow-up similarly concluded that dilation should remain the cornerstone of treatment.12PubMed. Vaginal dilation treatment in women with vaginal hypoplasia: a prospective one-year follow-up study
The method works best when patients are motivated and have adequate support, including clear instruction and follow-up visits. Some people use a bicycle-seat approach (the Ingram method), where they sit on a specially designed seat that applies gentle pressure via a dilator, which can feel less intrusive than manual dilation. Success rates are high, but the process can be emotionally taxing, particularly for teenagers who may not yet be sexually active and find the concept uncomfortable.
When Surgery Becomes the Path Forward
For patients who cannot tolerate dilation or for whom it fails, several surgical techniques exist to create a neovagina. The two most commonly compared are the McIndoe procedure, which uses a skin graft placed over a mold inserted into a surgically created space, and the Davydov procedure, a laparoscopic technique that lines the new canal with peritoneal tissue from inside the abdomen.
Research comparing the two shows that both produce similar vaginal dimensions at follow-up, with neovaginal lengths averaging around 6.5 to 6.7 centimeters in both groups.13Journal of Minimally Invasive Gynecology. Vaginoplasty in MRKH: A Single Center Experience The McIndoe technique is faster, typically taking about 30 to 60 minutes, while the Davydov procedure requires roughly 100 to 135 minutes and demands laparoscopic surgical expertise.14Journal of Minimally Invasive Gynecology. To Compare Efficacy of Vaginal Versus Laparoscopic Peritoneal Vaginoplasty in Women with MRKH Syndrome One comparative study found a somewhat higher rate of postoperative complications in the McIndoe group, though hospital stays were similar and most patients in both groups were sexually active within a year with no reported difficulty.15PubMed Central. Comparison of modified McIndoe and Davydov vaginoplasty in patients with MRKH syndrome in terms of anatomical results, sexual performance and satisfaction The choice between techniques often depends on institutional expertise and patient preference.
Sexual Function After Treatment
One of the first questions many patients and families have is whether a satisfying sex life is realistic. The short answer is yes, regardless of which approach is used. A study directly comparing dilation to surgical vaginoplasty found that even though the dilation group ended up with slightly shorter vaginal lengths, sexual function scores and quality of life were comparable between the two groups. The authors reinforced dilation as the recommended first-line therapy on that basis.16PubMed. Sexual function and quality of life after the creation of a neovagina in women with Mayer-Rokitansky-Küster-Hauser syndrome: comparison of vaginal dilation and surgical procedures
Long-term follow-up data after the Davydov procedure showed encouraging results, with sexually active patients scoring an average of about 31.5 out of 36 on a widely used sexual function questionnaire, which falls within the normal range.17PubMed Central. Long term sexual outcomes of Mayer Rokitansky Küster Hauser Syndrome patients after Uncu-modified Davydov procedure A systematic review noted that surgical patients tended to achieve greater vaginal length and reported somewhat higher sexual activity levels, though the commonly used questionnaire did not always agree with other assessment tools.18PubMed. Sexual satisfaction in patients with Mayer-Rokitansky-Küster-Hauser syndrome after surgical and non-surgical techniques: a systematic review The bottom line from the clinical literature is that satisfying sexual relationships are achievable with either approach, and the “best” method is the one that fits the individual’s circumstances and comfort level.
Paths to Biological Parenthood
Because the ovaries function normally, women with MRKH produce their own eggs. The absence of a uterus historically meant that gestational surrogacy was the only route to having a genetically related child. A systematic review of IVF outcomes using surrogates for MRKH patients found a live birth rate of about 18% per cycle and roughly 54% per patient across multiple cycles, which is generally in line with IVF success rates in other populations.19Reproductive BioMedicine Online. The reproductive potential of patients with Mayer–Rokitansky–Küster–Hauser syndrome using gestational surrogacy: a systematic review Surrogacy remains an important option, though it carries legal complexity and significant cost depending on where you live.
Uterus transplantation has changed the landscape. The concept moved from experimental to real after initial successes in Sweden in the early 2010s, with women born without a uterus carrying pregnancies and delivering healthy babies using a transplanted organ.20PubMed Central. Uterus Transplantation as a Therapy Method in Mayer-Rokitansky-Küster-Hauser Syndrome A milestone came in 2018 with the first documented live birth from a uterus transplanted from a deceased donor, establishing that living donors are not strictly necessary.21The Lancet. Livebirth after uterine transplantation from a deceased donor
Results from the Dallas Uterus Transplant Study showed that among 14 patients with successful transplants, all achieved at least one clinical pregnancy. In about 71% of cases, the very first embryo transfer resulted in pregnancy, and the median time from transplant to first live birth was a little over 14 months. A total of 13 live births occurred in 12 of those patients.22PubMed. Clinical pregnancy rates and experience with in vitro fertilization after uterus transplantation: Dallas Uterus Transplant Study These are striking numbers, though the procedure remains available only at a handful of specialized centers worldwide and requires immunosuppressive medication throughout the pregnancy. The transplanted uterus is typically removed after one or two pregnancies to avoid the long-term risks of those drugs.
What Patients Think About Uterus Transplantation
A survey of 281 women with MRKH found that after reviewing educational material about the procedure, about 73% would consider having a uterus transplant, and 86% believed it should be available to all women with uterine infertility. Roughly 78% felt insurance should cover it, and nearly half were willing to pay more than $10,000 out of pocket.23PubMed Central. Perspectives of 281 patients with Mayer-Rokitansky-Küster-Hauser Syndrome on uterine transplantation Insurance coverage for uterus transplantation is still rare, and the procedure is not yet available outside of research protocols in many countries, which creates a gap between patient demand and access.
The Emotional Weight of the Diagnosis
Receiving a diagnosis of MRKH during adolescence carries a psychological burden that clinical summaries tend to understate. A qualitative study exploring the lived experience of young women with the condition identified recurring themes: a sense that the diagnosis hindered their independence, heightened sensitivity to feeling different from peers, difficulty managing intimacy and romantic relationships, and a perceived threat to their identity as women.24PubMed. Exploring the psychological impact of Mayer-Rokitansky-Küster-Hauser syndrome on young women: An interpretative phenomenological analysis Many described carefully managing what they revealed to others in order to minimize the impact of their diagnosis on social interactions.
Disclosure is a recurring source of anxiety. Research on how women with MRKH share health information with friends and partners found that the diagnosis triggers ongoing worries about when and how to tell others, and that healthcare providers often fail to offer adequate guidance on that front.25PubMed. The Lived Experience of MRKH: Sharing Health Information with Peers The fear is not abstract: many women worry that a partner will reject them or that friends will treat them differently. Peer support networks, both online and in person, have become an important resource, giving women a space where the condition is already understood and the need to explain or justify is removed.
There is also evidence that the mental health implications extend beyond situational distress. A study comparing psychiatric outcomes in women with Müllerian duct aplasia to reference populations found that rates of anxiety and depressive disorders were roughly twice as high as in male reference groups, though differences compared to female reference groups were smaller.26PubMed Central. Psychiatric Comorbidities in Women With Complete Androgen Insensitivity Syndrome or Müllerian Duct Aplasia/Agenesis A case report from Bangladesh emphasized that culturally sensitive counseling and a multidisciplinary care team can meaningfully improve both physical and psychological outcomes, particularly in settings where reproductive capacity is closely tied to social standing.27PubMed Central. Müllerian Agenesis Presenting as Primary Amenorrhea in a 16‐Year‐Old Girl From a Low‐Resource Setting in Bangladesh: Psychological Impact and Multidisciplinary Management
Distinguishing MRKH From Other Conditions
Müllerian agenesis is not the only condition that causes primary amenorrhea with an absent or non-functional uterus. Complete androgen insensitivity syndrome (CAIS) can present similarly on the surface: a young person who looks female, goes through breast development, but does not menstruate. The key difference is that individuals with CAIS have XY chromosomes and internal testes rather than ovaries, and they lack a uterus for an entirely different developmental reason. A simple blood test for chromosomes quickly distinguishes the two.
Other causes of primary amenorrhea include conditions affecting the hypothalamus, pituitary gland, or ovaries. What sets MRKH apart is that hormonal function is intact. The ovaries cycle normally, estrogen and progesterone levels are appropriate, and ovulation occurs on schedule. The sole problem is anatomical: the structures that would normally receive a fertilized egg and allow menstruation to happen simply are not there. This distinction matters because it means hormonal treatments are not part of the picture and the focus is instead on the structural and reproductive aspects of care.
Hearing Loss and Cardiac Findings in Type II
While kidney and spinal anomalies get the most attention in MRKH Type II, hearing deficits and cardiac malformations also appear in the spectrum, though less frequently. Auditory anomalies tend to involve conductive or sensorineural hearing loss, and cardiac findings can range from minor structural variants to clinically relevant defects. Because these are less commonly screened for, they can go undiagnosed unless clinicians are specifically aware of the association. A comprehensive initial evaluation for anyone diagnosed with MRKH ideally includes not just pelvic and renal imaging but also a hearing screen and cardiac evaluation, particularly if any skeletal anomalies are present.